Entheon Biomedical Corp
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Entheon Biomedical Corp (ENTBF) - Total Liabilities
Latest total liabilities as of March 2025: $16.12K USD
Based on the latest financial reports, Entheon Biomedical Corp (ENTBF) has total liabilities worth $16.12K USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Entheon Biomedical Corp - Total Liabilities Trend (2018–2025)
This chart illustrates how Entheon Biomedical Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Entheon Biomedical Corp Competitors by Total Liabilities
The table below lists competitors of Entheon Biomedical Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
STATE STREET - Dusseldorf Stock Exchang
DU:ZYA
|
Germany | €312.65 Billion |
|
OSHKOSH
BE:OK3
|
Germany | €5.77 Billion |
|
SRIVARU Holding Limited
PINK:SVUHF
|
USA | $1.54 Million |
|
HYUNGJI INNOVATION & CREATIVE Co.Ltd
KQ:011080
|
Korea | ₩25.13 Billion |
|
Pharmadrug Inc
PINK:LMLLF
|
USA | $2.07 Million |
|
Tie Holding NV
F:TJH7
|
Germany | €2.87 Million |
|
d'Alba Global
KO:483650
|
Korea | ₩54.09 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Entheon Biomedical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 27.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Entheon Biomedical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Entheon Biomedical Corp (2018–2025)
The table below shows the annual total liabilities of Entheon Biomedical Corp from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $39.81K | -53.34% |
| 2024-03-31 | $85.33K | -44.83% |
| 2023-03-31 | $154.65K | -83.33% |
| 2022-03-31 | $927.71K | +27.40% |
| 2021-03-31 | $728.19K | +2496.88% |
| 2020-03-31 | $28.04K | -28.05% |
| 2019-03-31 | $38.97K | -78.97% |
| 2018-03-31 | $185.28K | -- |